USD 98.3
(2.21%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 1.03 Billion USD | 87.58% |
2022 | 672 Million USD | 15.86% |
2021 | 580 Million USD | 220.33% |
2020 | -482 Million USD | -157.75% |
2019 | -187 Million USD | 24.6% |
2018 | -248 Million USD | -222.08% |
2017 | -77 Million USD | -870.0% |
2016 | 10 Million USD | -97.51% |
2015 | 401.11 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 327.97 Million USD | -13.59% |
2024 Q1 | 368 Million USD | -18.98% |
2023 Q2 | 270 Million USD | 0.75% |
2023 Q4 | 454.18 Million USD | 55.01% |
2023 Q3 | 293 Million USD | 8.52% |
2023 Q1 | 268 Million USD | 1176.19% |
2023 FY | 1.26 Billion USD | 87.58% |
2022 Q4 | 21 Million USD | -89.76% |
2022 FY | 672 Million USD | 15.86% |
2022 Q3 | 205 Million USD | 2.5% |
2022 Q1 | 246 Million USD | 35.16% |
2022 Q2 | 200 Million USD | -18.7% |
2021 Q1 | 149 Million USD | 5.67% |
2021 Q3 | 20 Million USD | -91.27% |
2021 FY | 580 Million USD | 220.33% |
2021 Q4 | 182 Million USD | 810.0% |
2021 Q2 | 229 Million USD | 53.69% |
2020 Q4 | 141 Million USD | 209.3% |
2020 Q1 | -28 Million USD | 58.82% |
2020 Q2 | -466 Million USD | -1564.29% |
2020 Q3 | -129 Million USD | 72.32% |
2020 FY | -482 Million USD | -157.75% |
2019 Q4 | -68 Million USD | -277.78% |
2019 Q2 | -53 Million USD | -10.42% |
2019 Q1 | -48 Million USD | 36.0% |
2019 FY | -187 Million USD | 24.6% |
2019 Q3 | -18 Million USD | 66.04% |
2018 Q2 | 38 Million USD | -55.29% |
2018 FY | -248 Million USD | -222.08% |
2018 Q4 | -75 Million USD | 73.59% |
2018 Q3 | -284 Million USD | -847.37% |
2018 Q1 | 85 Million USD | 77.08% |
2017 Q4 | 48 Million USD | 0.0% |
2017 FY | -77 Million USD | -870.0% |
2016 FY | 10 Million USD | -97.51% |
2015 FY | 401.11 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
AptarGroup, Inc. | 404.01 Million USD | -157.166% |
Baxter International Inc. | 390 Million USD | -166.41% |
Becton, Dickinson and Company | 2.42 Billion USD | 57.155% |
Bausch + Lomb Corporation | 130 Million USD | -699.231% |
Haemonetics Corporation | 164.88 Million USD | -530.144% |
Envista Holdings Corp | 31.5 Million USD | -3198.413% |
ResMed Inc. | 1.31 Billion USD | 21.281% |
Teleflex Incorporated | 506.31 Million USD | -105.209% |
Warby Parker Inc. | -71.99 Million USD | 1543.136% |
West Pharmaceutical Services, Inc. | 676 Million USD | -53.698% |